Correction: Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver (Oncogene, (2008), 27, 57, (7192-7200), 10.1038/onc.2008.356)

M. J. Gray*, N. A. Dallas, G. Van Buren, L. Xia, A. D. Yang, R. J. Somcio, P. Gaur, L. S. Mangala, P. E. Vivas-Mejia, F. Fan, A. M. Sanguino, G. E. Gallick, G. Lopez-Berestein, A. K. Sood, L. M. Ellis

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Original languageEnglish (US)
Pages (from-to)4619
Number of pages1
JournalOncogene
Volume39
Issue number23
DOIs
StatePublished - Jun 4 2020

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Fingerprint Dive into the research topics of 'Correction: Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver (Oncogene, (2008), 27, 57, (7192-7200), 10.1038/onc.2008.356)'. Together they form a unique fingerprint.

  • Cite this

    Gray, M. J., Dallas, N. A., Van Buren, G., Xia, L., Yang, A. D., Somcio, R. J., Gaur, P., Mangala, L. S., Vivas-Mejia, P. E., Fan, F., Sanguino, A. M., Gallick, G. E., Lopez-Berestein, G., Sood, A. K., & Ellis, L. M. (2020). Correction: Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver (Oncogene, (2008), 27, 57, (7192-7200), 10.1038/onc.2008.356). Oncogene, 39(23), 4619. https://doi.org/10.1038/s41388-020-1310-8